Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Fluconazole versus itraconazole in therapy of oropharyngeal candidiasis in cancer patients: a prospective comparative randomized trial.

Studena V, Sycova Z, Helpianska L, Sorkovska D, Pichna P, Lacka J, Hlavacova E, Oravcova E, Krcmery V Jr, Studena M, et al.

J Chemother. 1995 Nov;7 Suppl 4:204-5. No abstract available.

PMID:
8904157
2.

Itraconazole and fluconazole in oropharyngeal candidiasis.

van der Bijl P, Arendorf TM.

Ann Dent. 1993 Winter;52(2):12-6. Review.

PMID:
8267372
3.

Randomized trial of itraconazole oral solution for oropharyngeal candidiasis in HIV/AIDS patients.

Graybill JR, Vazquez J, Darouiche RO, Morhart R, Greenspan D, Tuazon C, Wheat LJ, Carey J, Leviton I, Hewitt RG, MacGregor RR, Valenti W, Restrepo M, Moskovitz BL.

Am J Med. 1998 Jan;104(1):33-9.

PMID:
9528717
4.

An open multicentre comparative study of the efficacy, safety and tolerance of fluconazole and itraconazole in the treatment of cancer patients with oropharyngeal candidiasis.

Oude Lashof AM, De Bock R, Herbrecht R, de Pauw BE, Krcmery V, Aoun M, Akova M, Cohen J, Siffnerová H, Egyed M, Ellis M, Marinus A, Sylvester R, Kullberg BJ; EORTC Invasive Fungal Infections Group.

Eur J Cancer. 2004 Jun;40(9):1314-9.

PMID:
15177489
5.

Oropharyngeal and esophageal candidiasis in immunocompromised patients: treatment issues.

Darouiche RO.

Clin Infect Dis. 1998 Feb;26(2):259-72; quiz 273-4. Review. No abstract available.

PMID:
9502438
6.

A double-blind comparison of itraconazole oral solution and fluconazole capsules for the treatment of oropharyngeal candidiasis in patients with AIDS.

Phillips P, De Beule K, Frechette G, Tchamouroff S, Vandercam B, Weitner L, Hoepelman A, Stingl G, Clotet B.

Clin Infect Dis. 1998 Jun;26(6):1368-73.

PMID:
9636865
7.

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions.

Pons V, Greenspan D, Lozada-Nur F, McPhail L, Gallant JE, Tunkel A, Johnson CC, McCarty J, Panzer H, Levenstein M, Barranco A, Green S.

Clin Infect Dis. 1997 Jun;24(6):1204-7.

PMID:
9195083
9.

[A new pharmaceutical concept for the therapy of oropharyngeal and esophageal candidiasis with fluconazole].

Wildfeuer A, Laufen H, Yeates RA, Zimmermann T.

Mycoses. 1996;39 Suppl 1:123-6. German.

PMID:
8767284
10.

Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial.

Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ.

Clin Infect Dis. 2008 Nov 15;47(10):1270-6. doi: 10.1086/592578.

PMID:
18840077
11.

[Fluconazole in oro-pharyngeal candidiasis in retroviral infection (experience in Dakar)].

Sow PS, Diop BM, Ndiaye I, Faye MA, Coll-Seck AM.

Dakar Med. 1993;38(1):85-8. French.

PMID:
7882856
12.

A systematic review of the effectiveness of antifungal drugs for the prevention and treatment of oropharyngeal candidiasis in HIV-positive patients.

Patton LL, Bonito AJ, Shugars DA.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Aug;92(2):170-9.

PMID:
11505264
13.

Patterns of fluconazole susceptibility in isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis due to Candida albicans.

Laguna F, Rodríguez-Tudela JL, Martínez-Súarez JV, Polo R, Valencia E, Díaz-Guerra TM, Dronda F, Pulido F.

Clin Infect Dis. 1997 Feb;24(2):124-30.

PMID:
9114134
14.

Efficacy of fluconazole and itraconazole in the treatment of oral candidiasis in HIV patients.

Menon T, Umamaheswari K, Kumarasamy N, Solomon S, Thyagarajan SP.

Acta Trop. 2001 Oct 22;80(2):151-4.

PMID:
11600094
15.

Efficacy of fluconazole in the treatment of upper gastrointestinal candidiasis in neutropenic patients with cancer: factors influencing the outcome.

Akova M, Akalin HE, Uzun O, Hayran M, Tekuzman G, Kansu E, Aslan S, Telatar H.

Clin Infect Dis. 1994 Mar;18(3):298-304.

PMID:
8011807
17.

Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients.

Linpiyawan R, Jittreprasert K, Sivayathorn A.

Int J Dermatol. 2000 Nov;39(11):859-61.

PMID:
11123451
18.

Correlation of in vitro fluconazole susceptibility with clinical outcome for severely ill patients with oropharyngeal candidiasis.

Arikan S, Akova M, Hayran M, Ozdemir O, Erman M, Gür D, Unal S.

Clin Infect Dis. 1998 Apr;26(4):903-8.

PMID:
9564473
19.

A prospective randomized trial of itraconazole vs fluconazole for the prevention of fungal infections in patients with acute leukemia and hematopoietic stem cell transplant recipients.

Oren I, Rowe JM, Sprecher H, Tamir A, Benyamini N, Akria L, Gorelik A, Dally N, Zuckerman T, Haddad N, Fineman R, Dann EJ.

Bone Marrow Transplant. 2006 Jul;38(2):127-34. Epub 2006 Jun 5.

PMID:
16751782
20.

Fluconazole for oropharyngeal candidiasis in anti-HIV positive haemophiliacs.

Lim SG, Lee CA, Hales M, O'Doherty M, Winter M, Kernoff PB.

Aliment Pharmacol Ther. 1991 Apr;5(2):199-205.

PMID:
1888820

Supplemental Content

Support Center